-
FDA Reviewing New Oral Drug for ALS Application
Aquestive is seeking FDA approval of its new drug application for Exservan oral film riluzole, an ALS therapy that dissolves on the tongue. Read more about this drug and its application for approval here.
What do you think of this news? What do you think about oral drugs like this in general?
Sorry, there were no replies found.
Log in to reply.